Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Multiple Sclerosis Drugs Market Research Reports

Titlepublishedprice

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Insight, 2017

By Delve Insight
"...... vities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Primary Progressive Multiple Sclerosis (PPMS) by development stage, therapy type, route of administration and molecule type is ......"
28-Jul-2017$1250

Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2017

By Delve Insight
"...... inical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Relapsing Multiple Sclerosis (RMS) by development stage, therapy type, route of administration and molecule type is also covered in the report. It al......"
28-Jul-2017$1250

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2017

By Delve Insight
"...... activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Secondary Progressive Multiple Sclerosis (SPMS) by development stage, therapy type, route of administration and molecule ty......"
28-Jul-2017$1250

Primary Progressive Multiple Sclerosis (PPMS) - Epidemiology Insights to 2025

By Delve Insight
"...... storical and forecasted data of Primary Progressive Multiple Sclerosis (PPMS). The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Primary Progressive Multiple Scl......"
28-Jul-2017$2950

Primary Progressive Multiple Sclerosis (PPMS) - Market Insights, Epidemiology and Market Forecast - 2025

By Delve Insight
"...... in and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Primary Progressive Multiple Sclerosis (PPM......"
28-Jul-2017$5750

Relapsing Multiple Sclerosis (RMS) - Epidemiology Insights to 2025

By Delve Insight
"...... d data of Relapsing Multiple Sclerosis (RMS). The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Relapsing Multiple Sclerosis (RMS). The report contains the targe......"
28-Jul-2017$2950

Relapsing Multiple Sclerosis (RMS) - Market Insights, Epidemiology and Market Forecast - 2025

By Delve Insight
"...... dy period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Relapsing Multiple Sclerosis (RMS) . It enables understanding of ......"
28-Jul-2017$5750

Secondary Progressive Multiple Sclerosis (SPMS) - Epidemiology Insights to 2025

By Delve Insight
"...... y historical and forecasted data of Secondary Progressive Multiple Sclerosis (SPMS). The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Secondary Progressive Mult......"
28-Jul-2017$2950

Secondary Progressive Multiple Sclerosis (SPMS) - Market Insights, Epidemiology and Market Forecast - 2025

By Delve Insight
"...... Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Secondary Progressive Multiple Sclerosi......"
28-Jul-2017$5750

Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Relapsing Multiple Sclerosis (RMS) which can......"
01-Jul-2017$1500

Avail upto 25% Discount on below Publisher Reports.